Musetti SN, Huang L. Tinagl1 gene therapy suppresses growth and remodels the microenvironment of triple negative breast cancer. Mol Pharm. 2021 May 3;18(5):2032-8. doi: 10.1021/acs.molpharmaceut.1c00008
Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.